349 related articles for article (PubMed ID: 36826125)
1. Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers.
Lee DY; Salahuddin T; Iqbal J
Curr Oncol; 2023 Feb; 30(2):2127-2143. PubMed ID: 36826125
[TBL] [Abstract][Full Text] [Related]
2. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
3. LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy.
Mamun MAA; Zhang Y; Zhao JY; Shen DD; Guo T; Zheng YC; Zhao LJ; Liu HM
J Biomed Sci; 2023 Jul; 30(1):60. PubMed ID: 37525190
[TBL] [Abstract][Full Text] [Related]
4. Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential.
Bao L; Zhu P; Mou Y; Song Y; Qin Y
Front Immunol; 2023; 14():1214675. PubMed ID: 37483603
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
[TBL] [Abstract][Full Text] [Related]
6. Lysine-specific demethylase 1 (LSD1) serves as an potential epigenetic determinant to regulate inflammatory responses in mastitis.
Jingjing W; Zhikai W; Xingyi Z; Peixuan L; Yiwu F; Xia W; Youpeng S; Ershun Z; Zhengtao Y
Int Immunopharmacol; 2021 Feb; 91():107324. PubMed ID: 33385711
[TBL] [Abstract][Full Text] [Related]
7. Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.
Nguyen EM; Taniguchi H; Chan JM; Zhan YA; Chen X; Qiu J; de Stanchina E; Allaj V; Shah NS; Uddin F; Manoj P; Liu M; Cai SF; Levine R; Quintanal-Villalonga Á; Sen T; Chow A; Rudin CM
J Thorac Oncol; 2022 Aug; 17(8):1014-1031. PubMed ID: 35691495
[TBL] [Abstract][Full Text] [Related]
8. Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer.
Tan AHY; Tu W; McCuaig R; Hardy K; Donovan T; Tsimbalyuk S; Forwood JK; Rao S
Front Immunol; 2019; 10():1351. PubMed ID: 31249575
[TBL] [Abstract][Full Text] [Related]
9. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
Murray-Stewart T; Woster PM; Casero RA
Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance.
Agboyibor C; Dong J; Effah CY; Drokow EK; Ampomah-Wireko M; Pervaiz W; Sangmor A; Ma X; Li J; Liu HM; Zhang P
Biomed Pharmacother; 2023 Jan; 157():113934. PubMed ID: 36395607
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
12. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components.
Janzer A; Lim S; Fronhoffs F; Niazy N; Buettner R; Kirfel J
Biochem Biophys Res Commun; 2012 May; 421(4):665-70. PubMed ID: 22542627
[TBL] [Abstract][Full Text] [Related]
13. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Mao F; Shi YG
Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
[TBL] [Abstract][Full Text] [Related]
14. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
17. Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Johnson JD; Alejo S; Jayamohan S; Sareddy GR
Expert Opin Ther Targets; 2023; 27(12):1177-1188. PubMed ID: 37997756
[TBL] [Abstract][Full Text] [Related]
18. Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications.
Yang FF; Xu XL; Hu T; Liu JQ; Zhou JZ; Ma LY; Liu HM
J Med Chem; 2023 Apr; 66(7):4275-4293. PubMed ID: 37014989
[TBL] [Abstract][Full Text] [Related]
19. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
[TBL] [Abstract][Full Text] [Related]
20. Regulation of T cells in the tumor microenvironment by histone methylation: LSD1 inhibition-a new direction for enhancing immunotherapy.
Xueqing X; Yongcan P; Wei L; Qingling Y; Jie D
Heliyon; 2024 Jan; 10(2):e24457. PubMed ID: 38312620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
